Research advance directives are a proposed mechanism for ensuring that decisions with regard to research participation adhere to preferences voiced by persons with Alzheimer disease (AD) before losing decisional capacity. Although this approach rests on the assumption that preferences with regard to research participation are consistent over time, little is known about the stability of such preferences. The purpose of this study was to evaluate the temporal stability of older adults' receptiveness to participation in clinical trials, neuroimaging studies, and psychosocial investigations on AD. One hundred and four participants in the University of Pittsburgh Alzheimer Disease Research Center were annually surveyed with regard to their willingness to be contacted with regard to clinical drug trials, neuroimaging studies, and psychosocial research for which they might be eligible. Receptiveness to contact with regard to AD research was compared at 2 time points, 1 year apart. At baseline, most respondents were willing to be contacted with regard to their eligibility for drug trials, imaging studies, and psychosocial research. Thirty-seven percent of respondents voiced a different set of preferences at year 2 as compared with year 1. Differences included both increased and decreased willingness to be contacted. Neither stability of preferences nor direction of change (more vs. less willing) varied by diagnostic group. Bivariate analyses revealed that participation in at least 1 ancillary research study was associated with an overall increase in willingness to be contacted. We conclude that a significant proportion of research-friendly individuals voice different sets of preferences with regard to the possibility of research participation when queried at different points in time. Amenability to participating in clinical research on AD is a relatively dynamic personal attribute that may be influenced by personal experience with research participation. This finding has relevance for the policy debate around research advance directives, an approach which assumes that preferences with regard to research participation are consistent over time.
T he burgeoning demand for and soaring costs associated with dementia care make Alzheimer disease (AD) a top priority for the federal research agenda 1 and a major focus of industry-sponsored neuropharmacological development. 2 Although there is a clear need to involve large and representative pools of individuals into clinical research on AD, the recruitment of such persons is complicated by numerous factors including concerns about multiple medical comorbidities, questions of decisional capacity, [3] [4] [5] and the issue of involving participants' family members in enrollment decisions. 6, 7 Indeed, very few individuals with AD ever become involved in clinical research and those who do volunteer for research rarely remain involved for the duration of their illness. 8 Interactions between study recruiters and potential participants are especially challenging given that specific neuropsychological deficits in the domains of memory and language can make it difficult for an AD-affected individual to understand, recall, or discuss with others information that may be conveyed during a research recruitment exchange. As such deficits can undermine the authenticity of informed consent, many studies have sought to (a) identify reliable methods of determining whether or not an individual can autonomously consent to research, [9] [10] [11] [12] and (b) determine how enrollment decisions should be made when one lacks the capacity to consent. [13] [14] [15] [16] With regard to the latter, research advance directives are a proposed mechanism for ensuring that decisions with regard to AD research participation adhere to preferences voiced by patients before losing decisional capacity. 17 Although this approach rests on the assumption that preferences with regard to research participation are consistent over time, little is known about the stability of such preferences. The purpose of this investigation, therefore, was to evaluate the temporal stability of older adults' receptiveness to participation in various types of clinical research on AD.
METHODS
Between January 1, 2006 and February 1, 2008, participants of the University of Pittsburgh Alzheimer Disease Research Center (ADRC) were queried with regard to their willingness to be contacted with regard to ancillary research projects for which they might be eligible. This longitudinal analysis aims to characterize the nature and stability of such preferences over time. The University of Pittsburgh Institutional Review Board approved this secondary analysis of research preferences and waived the requirement for written informed consent.
Overview of ADRC Procedures
All ADRC participants provide written informed consent or assent (with proxy authorization) on initial presentation to the center. A description of the baseline multidisciplinary ADRC clinical research evaluation has been published previously. 17 Once enrolled, center participants undergo annual neurological, psychiatric, and neuropsychological evaluations. Depending on interest and eligibility, ADRC participants may, over the course of their involvement with the center, also choose to participate in clinical drug trials, neuroimaging studies, psychosocial research, and other studies, above and beyond their involvement with the ADRC. Annual checks of receptiveness to being contacted for these types of ancillary studies are one of several mechanisms for procuring ongoing consent to involvement in the center.
Sample
ADRC participants include individuals with diagnoses of AD and related cognitive disorders as well as normal control participants. After a standardized dementia evaluation, 18 each case is discussed at a Consensus Conference meeting where diagnostic criteria are applied to determine the presence or absence of AD 19 or another form of dementia. A diagnosis of mild cognitive impairment may be applied to individuals who have subjective cognitive complaints and score in the mildly impaired range on neuropsychological testing, but whose deficits are not severe enough to qualify for a clinical diagnosis of dementia. 20 Control participants are the individuals who are recruited from the community to serve as healthy study volunteers. Control participants have neither subjective nor objective evidence of cognitive impairment at the time of presentation to the ADRC. All participants and controls must have a study partner (eg, spouse, sibling, child, or close friend) who has frequent interaction with them and can independently report on their functioning.
Research Preferences
Four to six weeks after the baseline cognitive evaluation, ADRC participants and their family members meet with a study team neurologist and a social worker to discuss the final diagnostic impression. At that time, participants are provided with treatment recommendations and given basic information about ongoing and anticipated clinical research studies involving ADRC investigators. It is explained to participants that the bulk of clinical research at the ADRC falls into 1 of 3 categories: randomized controlled trials (RCTs), neuroimaging studies, and psychosocial investigations. Participants are then asked whether, during the next 12 months, they would like to be contacted about research studies falling into each category (RCT, imaging, psychosocial research), if a basic screening of their registry data indicate that they may be eligible. Responses are elicited in a yes/no manner for each type of research, with the understanding that a willingness to be contacted implied receptiveness to such a study at a general level and will not be treated as a research advance directive. Formal assessments of participants' decisional capacity are viewed as decision specific and are not conducted as part of the general assessment of research preferences. The assessment of research preferences is repeated at 12-month intervals. As with baseline, these assessments follow the disclosure of updated diagnostic impressions and clinical treatment recommendations.
Analytic Approach
We used basic descriptive statistics to characterize participants' clinical and sociodemographic features and research preferences. Kappa values were calculated to test concordance of stated preferences at assessment years 1 and 2. Characteristics of preference changers were compared with nonchangers using analysis of variance and w 2 analyses as appropriate. Bivariate analyses were conducted to identify to correlates of overall willingness to be contacted at year 2.
RESULTS

Sample Characteristics
One hundred and four participants completed both baseline and 1-year follow-up assessments of research preferences. Of these, 63 had a diagnosis of AD or other dementia, 31 met diagnostic criteria for mild cognitive impairment, and 10 had no cognitive disorder. More than half (n=60; 58%) were women and the vast majority (n=102; 98%) were white. The average age of participants was 76 years (range: 54 to 94 y); the average age of primary family members/study partners was 70 years (range: 45 to 92 y). In 67% of these cases (n=70), the participant's primary family member was a spouse and in 22% of cases (n=23), participants were accompanied to the research center by an adult child. The remaining participants were accompanied by a sibling (n=2), other relative (n=1), friend or neighbor (n=1), or "other" individual (n=2). None was accompanied by a paid caregiver. In most cases (n=79; 76%), ADRC participants lived with the individual who accompanied them to the center. On average, participants had 14 years (range: 8 to 22 y) and family members/study partners had 15 years (range: 10 to 22 y) of formal education. Nearly half of the ADRC participants (n=48; 46%) reported having a family history of dementia. Of note, demographic data for family members were missing in 5 cases.
Overall Willingness to be Contacted
At baseline, most ADRC participants were willing to be contacted with regard to potential opportunities to participate in clinical research on AD; and, willingness to be contacted increased as the general level of risk associated with a given research category decreased. Specifically, 77% of respondents were willing to be contacted with regard to their eligibility for RCT studies, 78% for imaging studies, and 87% for psychosocial research studies. At year 2, over one-third of respondents voiced a different set of preferences as compared with year 1. As shown in Table 1 , changes in preference included both increased and decreased willingness to be contacted for research participation.
Sociodemographic and Clinical Factors
To identify potential correlates of change in participants' preferences over time, we examined whether various sociodemographic or clinical factors were associated with the presence of any change in a given respondent's set of preferences for being contacted. Research preference sets (eg, yes-no-no to contact for RCT, imaging, and psychosocial research, respectively) that were identical from year 1 to year 2 were categorized as unchanged, whereas a discrepant response with regard to any of the 3 types of research was categorized as a changed preference set. As shown in Table 2 , analysis of variance and w 2 analyses showed no differences between preference changers and nonchangers in terms of sex, or on such clinical factors as: cognitive diagnosis, family history of dementia, global cognitive functioning, or disease progression.
Those who changed their preferences with regard to RCTs differed from nonchangers on the variable of age. Additional scrutiny of the data revealed that older individuals were more likely to voice a different preference (either increased or decreased willingness for contact) with regard to RCTs at year 2, than were younger individuals. Second, our comparison of preference changers to nonchangers (Table 2) showed that, in the case of neuroimaging research, there were between group differences in average years of education. Having more years of formal education was associated with having stable, or unchanging, preferences for contact with regard to neuroimaging research. Additional analysis showed that 35% (n=16) of participants with 12 or fewer years of education voiced a different preference for contact with regard to neuroimaging research at year 2, compared with only 12% (n=7) of those with 13 or more years of education (w 2 =7.7; df=3;
P=0.05). Of the 16 preference changers with 12 or fewer years of education, 10 were more willing and 6 were less willing to be contacted with regard to neuroimaging studies at year 2 as compared with year 1.
Personal Experience With Clinical Research
Scrutiny of ancillary study tracking data indicate that individuals in the current sample participated in an average of 1 clinical research study (M=1.16; SD=1.43). Although participation in an ancillary study was not associated with change in willingness to be contacted (w 2 =0.501, df=1, P=0.479), there was a positive association between enrollment in at least 1 clinical research study and overall willingness to be contacted with regard to other studies at year 2 (F=4.88, P=0.029).
DISCUSSION
This study evaluated the temporal stability of research preferences in a sample of research-friendly individuals who 
have a reasonable likelihood of being recruited for clinical research on AD or related disorders during the course of their dementia or normal cognitive aging trajectory. We found that whereas a majority of older adults with and without cognitive impairment hold stable preferences with regard to willingness to be contacted for research participation, many do not. Over one-third of respondents voiced a different set of preferences for being contacted about opportunities for research participation at year 2 as compared with year 1. Differences included both increased and decreased willingness to be contacted. It should be noted that this study evaluated only the stability of individuals' willingness to being contacted about various types of research and did not evaluate the stability of preferences with regard to current or future research enrollment. Receptiveness to clinical research is a broad construct that, in our view, serves as a conceptual antecedent to enrollment decision-making. That is, only those who are receptive to the idea of research participation will go on to engage, or have their proxies engage, in enrollment decisions. Enrollment decision-making may occur either in advance (as in the case of a research advance directive) or in real-time and is associated with strict requirements for capacity assessment.
Understanding Changes in Preference Sets
Commentators who acknowledge that research preferences may fluctuate or change over one's course of dementia, generally do so out of concern that later course expressions of preference by persons with dementia will be erratic and/or may conflict with statements made when cognitive functioning was less, or not all, impaired. 21 Interestingly, our data fail to support a link between cognitive functioning and stability of research preferences.
The mean year 2 MMSE score of those voicing any change in their willingness for contact was 20; a value which, in other studies has been associated with a reasonable likelihood of being decisionally intact on formal assessment. 22 In this study, individuals with and without cognitive disorders were equally likely to change their preference profiles at year 2; and, changes in preference were not associated with a worsening of cognitive functioning. Our findings that being younger and more highly educated may influence the stability of one's research preferences did not hold across all 3 types of research, but nevertheless raise interesting questions that merit further exploration.
We found that participating in clinical research is positively associated with openness to doing so again in the future. There are many other mechanisms by which one's openness to participation in clinical research might change over time. In the context of dementia, the related notions of symptom progression and increased suffering or burden of illness, may lead a formerly research-averse patient, or her proxy, to consider research participation, especially when the study carries clear potential to directly benefit participants. At the same time, increasing perceptions of hopelessness, or an overwhelming degree of illnessassociated or general medical burden, may lessen one's willingness to assume the burdens associated with research participation. 23 Finally, it is possible that the changes in research receptiveness reported herein merely reflect ambivalence toward research participation and do not stem from explicit deliberation about research participation (eg, risk/benefit analysis) and/or reflection on core personal values.
Each of the above possibilities is problematic for programs and policies that would encourage the widespread adoption of research advance directives for enrollment decision-making among populations affected by fluctuating or deteriorating cognition. During real-time research recruitment and informed consent processes, learning details about an individual study may prompt meaningful deliberation within an individual who has previously been ambivalent. Yet, in the context of research advance directives, preference statements are based on general descriptions of what participation in certain types of research may entail. 24 Although these descriptions should be more detailed than the above-described overviews that were provided to ascertain receptiveness to research participation, there are significant limitations to the degree of detail that can be disclosed about studies which either have yet to be designed and/or may be implemented under a nearly unknowable array of clinical circumstances. 25 Our finding that receptiveness to clinical research may change over time suggests that decisionally intact individuals should periodically update statements concerning their preferences for future research participation.
Limitations
Our sample lacked racial and ethnic diversity. Another limitation of this retrospective analysis was our inability to examine the decision-making processes that led to the expressions of willingness for contact on which we report. Discussions of this study with ADRC social workers revealed that in all instances participants and their family members together answered questions concerning research preferences in a manner consistent with the shared decisionmaking practice seen in clinical care. Although mirroring "real world" practices may be viewed as a strength of this report, our inability to probe patients and their study partners with regard to their decision-making practices raises important questions about the extent to which patients', versus study partners', preferences drove responses to our queries with regard to willingness to be contacted.
